Iomai In the News Copyright (c) 2006 Iomai Inc. All rights reserved. http://phx.corporate-ir.net/preview/phoenix.zhtml?c=178326&p=irol-news&nyo=0 Iomai In the News en-us Fri, 25 Jul 2008 02:50:27 -0700 5 Iomai, Intercell Chief Scientific Officers to Speak on Future of Vaccines at BIO International Convention Today http://phx.corporate-ir.net/preview/phoenix.zhtml?c=178326&p=irol-newsArticle&ID=1167834&highlight= Iomai, Intercell Chief Scientific Officers to Speak on Future of Vaccines at BIO International Convention Today06/19/08 Thu, 19 Jun 2008 00:00:00 -0700 Iomai Announces Publication in The Lancet of Phase II Study Demonstrating Significant Efficacy of Travelers' Diarrhea Vaccine http://phx.corporate-ir.net/preview/phoenix.zhtml?c=178326&p=irol-newsArticle&ID=1165025&highlight= Iomai Announces Publication in The Lancet of Phase II Study Demonstrating Significant Efficacy of Travelers' Diarrhea Vaccine06/11/08 Wed, 11 Jun 2008 00:00:00 -0700 Iomai to Host Conference Call and Webcast Tomorrow, Tuesday, May 13, at 8:30 a.m. EDT http://phx.corporate-ir.net/preview/phoenix.zhtml?c=178326&p=irol-newsArticle&ID=1144057&highlight= Iomai to Host Conference Call and Webcast Tomorrow, Tuesday, May 13, at 8:30 a.m. EDT05/12/08 Mon, 12 May 2008 00:00:00 -0700 Intercell AG to Acquire Iomai Corporation to Expand Late Stage Product Pipeline and Strengthen Leadership in Vaccine Innovation http://phx.corporate-ir.net/preview/phoenix.zhtml?c=178326&p=irol-newsArticle&ID=1144054&highlight= Intercell AG to Acquire Iomai Corporation to Expand Late Stage Product Pipeline and Strengthen Leadership in Vaccine Innovation05/12/08 Mon, 12 May 2008 00:00:00 -0700 Iomai Receives HHS Approval to Begin Phase 2 Trial of H5N1 Influenza Adjuvant Patch http://phx.corporate-ir.net/preview/phoenix.zhtml?c=178326&p=irol-newsArticle&ID=1129568&highlight= Iomai Receives HHS Approval to Begin Phase 2 Trial of H5N1 Influenza Adjuvant Patch04/15/08 Tue, 15 Apr 2008 00:00:00 -0700 Iomai Wins Department of Defense Grant to Develop a Stable, Patch-Based Anthrax Vaccine http://phx.corporate-ir.net/preview/phoenix.zhtml?c=178326&p=irol-newsArticle&ID=1126992&highlight= Iomai Wins Department of Defense Grant to Develop a Stable, Patch-Based Anthrax Vaccine04/08/08 Tue, 08 Apr 2008 00:00:00 -0700 Iomai and Merck & Co., Inc. Evaluate Use of Iomai Immunostimulant Patch http://phx.corporate-ir.net/preview/phoenix.zhtml?c=178326&p=irol-newsArticle&ID=1125170&highlight= Iomai and Merck & Co., Inc. Evaluate Use of Iomai Immunostimulant Patch04/03/08 Thu, 03 Apr 2008 00:00:00 -0700 Iomai Reports 'Going Concern' Qualification in 10-K http://phx.corporate-ir.net/preview/phoenix.zhtml?c=178326&p=irol-newsArticle&ID=1123175&highlight= Iomai Reports 'Going Concern' Qualification in 10-K03/28/08 Fri, 28 Mar 2008 00:00:00 -0700 Study Finds Single Dose of Iomai Patch With Pandemic Flu Vaccine Achieves Protective Levels http://phx.corporate-ir.net/preview/phoenix.zhtml?c=178326&p=irol-newsArticle&ID=1120501&highlight= Study Finds Single Dose of Iomai Patch With Pandemic Flu Vaccine Achieves Protective Levels03/20/08 Thu, 20 Mar 2008 00:00:00 -0700 Iomai CEO to Speak at Cowen and Company Health Care Conference on Monday, March 17 http://phx.corporate-ir.net/preview/phoenix.zhtml?c=178326&p=irol-newsArticle&ID=1117617&highlight= Iomai CEO to Speak at Cowen and Company Health Care Conference on Monday, March 1703/11/08 Tue, 11 Mar 2008 00:00:00 -0700